Erratum: Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis
Saved in:
Main Author: | Frontiers Production Office (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis
by: Shashikant Srivastava, et al.
Published: (2021) -
Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
by: Frontiers Production Office
Published: (2023) -
Erratum: Advances in RIPK1 kinase inhibitors
by: Frontiers Production Office
Published: (2023) -
Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
by: Frontiers Production Office
Published: (2023) -
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
by: Frontiers Production Office
Published: (2022)